PRNewsWire
12 Mar 2026, 22:30 UTC · 26w ago
Verdict
Headline takes no side. We score PEPG −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The FDA has placed a partial clinical hold on PepGen's FREEDOM2-DM1 Phase 2 clinical trial due to questions regarding preclinical pharmacology and toxicology studies.
More negative than 98% of claims this week
Pomerantz LLP has launched an investigation into PepGen for potential securities fraud or unlawful business practices.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 80% of claims this week
PepGen's stock price declined 18.57% to $5.50 following the announcement of the FDA partial clinical hold.
So whatThis confirms the immediate negative market reaction and establishes a new, lower valuation baseline for the asset.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a partial FDA clinical hold on a trial and is the subject of a securities fraud investigation.
More negative than 80% of ticker scores this week
Mentioned as the subject of an investigation by Pomerantz Law Firm regarding investor claims.
More negative than 80% of ticker scores this week
Mentioned as the subject of an investigation by Pomerantz Law Firm regarding investor claims.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
47m ago
−52.8%
Price agrees with the score
$2.90 vs $6.15 close before publication (Mar 12) · not market-adjusted
PEPG chart →
